Search Count: 7
All
Selected
 |
Crystal Structure Of Human Chd1 Tandem Chromodomain In Complex With The Ethoxyquinoline-Based Inhibitor 2B
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-05-20 Classification: PEPTIDE BINDING PROTEIN Ligands: A1JUQ, DMS |
 |
Crystal Structure Of Human Chd1 Tandem Chromodomain In Complex With The Ethoxyquinoline-Based Inhibitor 2L
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2026-05-20 Classification: PEPTIDE BINDING PROTEIN Ligands: EDO, A1JUR, DMS |
 |
Crystal Structure Of Human Chd1 Tandem Chromodomain In Complex With The Ethoxyquinazoline-Based Inhibitor 1Q
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-05-20 Classification: PEPTIDE BINDING PROTEIN Ligands: A1JUO, DMS, EDO, BU3 |
 |
Crystal Structure Of Human Chd1 Tandem Chromodomain In Complex With The Ethoxyquinoline-Based Inhibitor 2N
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-05-20 Classification: PEPTIDE BINDING PROTEIN Ligands: A1JUP, EDO, DMS |
 |
Crystal Structure Of Human Chd1 Tandem Chromodomain In Complex With The Ethoxyquinoline-Based Inhibitor 2S
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2026-05-20 Classification: PEPTIDE BINDING PROTEIN Ligands: A1JUS, EDO |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2021-05-12 Classification: VIRAL PROTEIN Ligands: NAG, PO4, PEG |